Issues relating to haematological disease in adolescents - legal and ethical principles

Overview

Legal and ethical principles in haematological disease management span informed consent for high-risk treatment (transplant, experimental therapy), capacity assessment, and end-of-life decision-making - following the same general medical ethics/law framework applied specifically to the high-stakes decisions common in haemato-oncology
Particularly relevant given haematology involves some of medicine's most intensive treatments (allogeneic stem cell transplant, CAR-T cell therapy) with substantial treatment-related mortality risk, requiring especially thorough informed consent processes

High-risk treatments carry a genuine, sometimes substantial risk of treatment-related death or severe morbidity even when successful in controlling the underlying disease - informed consent for these treatments must clearly convey this risk-benefit balance, not simply the potential disease-control benefit

Capacity assessment (see assessment of capacity) applies specifically to major haematology treatment decisions - a patient may have capacity for some but not all treatment decisions depending on complexity, and this should be assessed decision-specifically
Advance care planning discussions are relevant even at diagnosis in high-risk haematological malignancy, given the genuine possibility of rapid deterioration or treatment-related crisis requiring pre-established goals of care

Clear, thorough documentation of consent discussions for high-risk treatments, including the specific risks discussed and the patient's understanding, protects both the patient's autonomy and provides medicolegal clarity
Early, proactive goals-of-care conversations (not deferred until a crisis) are particularly valuable in haematology given how rapidly some haematological malignancies or their treatment complications can progress

Informed consent for allogeneic transplant/CAR-T therapy, capacity assessment, advance care planning in newly diagnosed high-risk malignancy, substitute decision-making

The combination of high treatment-related risk and often rapid disease trajectories in haematological malignancy makes proactive, thorough legal/ethical process (consent, capacity assessment, advance care planning) especially important compared with many other medical specialties, given how little time may be available to address these issues once a crisis develops

5 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.